{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.1/OSP_Qualification_Plan_Schema.json",
    "Projects": [        
        {
            "Id": "Cimetidine",
            "Path": "../../Cimetidine-Model.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "ComparisonTimeProfile": [
                {
                    "Type": "X",
                    "Dimension": "Time",
                    "Unit": "h",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Concentration (mass)",
                    "Unit": "µg/ml",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Type": "X",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "PKRatioPlots": [
                {
                    "Type": "X",
                    "Dimension": "Age",
                    "Unit": "year(s)",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Type": "Y",
                    "Dimension": "Dimensionless",
                    "Unit": "",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AllPlots": [
            {
                "Project": "Cimetidine",
                "Simulation": "iv 100 mg (5 min), Grahnen 1979, n=3",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "iv 200 mg (30 min),Morgan 1983, n=4",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "iv 200 mg (5 min),Morgan 1983, n=6",
                "SectionId": 331
            },
            {
                "Project": "Cimetidine",
                "Simulation": "iv 200 mg, Larsson 1982, n=9",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "iv 200 mg, Mihaly 1984, n=6",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "iv 200 mg,Bodemar 1981, n=10",
                "SectionId": 331
            },
            {
                "Project": "Cimetidine",
                "Simulation": "iv 300 mg (2 min), Lebert 1981, n=1",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "iv 300 mg (2 min), Walkenstein 1978, n=6",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200 mg (tab), Bodemar 1979 (fasted)",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200 mg (tab), Bodemar 1979 (fed)",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200 mg, Bodemar 1981, n=10",
                "SectionId": 331
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200 mg, Burland 1975, caps",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200 mg, Burland 1975, sol",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200 mg, Kanto 1981, n=8",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200 mg, Mihaly 1984, n=8",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 200/400 mg QID, Bodemar 1981 (fasted)",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 300 mg (sol), Walkenstein 1978, n=24",
                "SectionId": 331
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 300 mg (tab), D'Angio 1986, n=6",
                "SectionId": 331
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 300 mg (tabl), Walkenstein 1978, n=12",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 300 mg QID (sol), Barbhaiya 1995, n=18",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 400 mg (tab), Bodemar 1979, n=10",
                "SectionId": 332
            },            {
                "Project": "Cimetidine",
                "Simulation": "po 400 mg (tab), Somogyi 1981, n=8",
                "SectionId": 332
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 400 mg (tab),Grahnen 1979, n=3",
                "SectionId": 332
            },            {
                "Project": "Cimetidine",
                "Simulation": "po 400 mg, Bodemar 1981, n=9",
                "SectionId": 331
            },
            {
                "Project": "Cimetidine",
                "Simulation": "po 800 mg (tab) qd, Tiseo 1998, n=18",
                "SectionId": 332
            },            {
                "Project": "Cimetidine",
                "Simulation": "po 800 mg, Bodemar 1981, n=9",
                "SectionId": 331
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plor for concentration in plasma",
                "SectionId": 32,
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "iv administration",
                        "Symbol": "Circle",
                        "OutputMappings": [
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 100 mg (5 min), Grahnen 1979, n=3",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Grahnen 1979 - IV 100 mg, Individual KN - Cimetidine - IV - 100 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 100 mg (5 min), Grahnen 1979, n=3",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Grahnen 1979 - IV 100 mg, Individual LH - Cimetidine - IV - 100 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 100 mg (5 min), Grahnen 1979, n=3",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Grahnen 1979 - IV 100 mg, Individual LOE - Cimetidine - IV - 100 mg - Plasma - indiv.",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 200 mg (30 min),Morgan 1983, n=4",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Morgan 1983 - IV 200 mg 30 min - Cimetidine - IV - 200 mg - Plasma - agg. (n=4)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 200 mg (5 min),Morgan 1983, n=6",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Morgan 1983 - IV 200 mg 5 min - Cimetidine - IV - 200 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 200 mg, Larsson 1982, n=9",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Larsson 1982 - IV 200 mg in normal renal function group - Cimetidine - IV - 200 mg - Plasma - agg. (n=9)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 200 mg, Mihaly 1984, n=6",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mihaly 1984 - IV 200 mg, beginning of treatment - Cimetidine - IV - 200 mg - Plasma - agg. (n=6)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 200 mg, Bodemar 1981, n=10",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bodemar 1981 - IV 200 mg - Cimetidine - IV - 200 mg - Plasma - agg. (n=10)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 300 mg (2 min), Lebert 1981, n=1",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Lebert 1981 - IV 300 mg - Cimetidine - IV - 300 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "iv 300 mg (2 min), Walkenstein 1978, n=6",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mouly 2002 - 400 mg, Day 1 - Efavirenz - PO - 400 mg - Plasma - agg. (n=8)",
                                "Color": "#FF0000"
                            }
                        ]
                    },
                    {
                        "Caption": "oral administration",
                        "Symbol": "Square",
                        "OutputMappings": [
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Mouly 2002, 200mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mouly 2002 - 200 mg, Day 10 - Efavirenz - PO - 200 mg - Plasma - agg. (n=8)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Mouly 2002, 400mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Mouly 2002 - 400 mg, Day 10 - Efavirenz - PO - 400 mg - Plasma - agg. (n=8)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Liu 2008, 400 mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Liu 2008 - Group 1, efavirenz alone - Efavirenz - PO - 400 mg - Plasma - agg. (n=16)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Liu 2008, 400 mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Liu 2008 - Group 2, efavirenz + placebo - Efavirenz - PO - 400 mg - Plasma - agg. (n=11)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Liu 2008, 400 mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Liu 2008 - Group 2, efavirenz alone - Efavirenz - PO - 400 mg - Plasma - agg. (n=11)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Dooley 2012, 600mg MD EM",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dooley 2012 - Extensive metabolizer - Efavirenz - PO - 600 mg - Plasma - agg. (n=34)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Dooley 2012, 600mg MD IM",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dooley 2012 - Intermediate metabolizer - Efavirenz - PO - 600 mg - Plasma - agg. (n=34)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Dooley 2012, 600mg MD PM",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Dooley 2012 - Slow metabolizer - Efavirenz - PO - 600 mg - Plasma - agg. (n=34)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Huang 2012, 600mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Huang 2013 - EFV administration alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=12)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Garg 2013, 600mg MD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Garg 2013 - Efavirenz without telaprevir - Efavirenz - PO - 600 mg - Plasma - agg. (n=28)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Malvestutto 2014, 600mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Malvestutto 2014 - Efavirenz alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=14)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Damle 2008, 600 mg PO OD",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Damle 2008 - Efavirenz alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=16)",
                                "Color": "#0000FF"
                            },
                            {
                                "Project": "Cimetidine",
                                "Simulation": "Soon 2010, 600mg MD over 28 days",
                                "Output": "Organism|PeripheralVenousBlood|Cimetidine|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Soon 2010 - Efavirenz alone - Efavirenz - PO - 600 mg - Plasma - agg. (n=12)",
                                "Color": "#0000FF"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Cimetidine",
            "Name": "Cimetidine",
            "Type": "Compound",
            "SectionId": 31
        },
        {
            "Project": "Cimetidine",
            "Name": "Sustiva",
            "Type": "Formulation",
            "SectionId": 31
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "1 Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "2 Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Id": 21,
                    "Title": "2.1 Modeling Strategy",
                    "Content": "Content/Section2.1_Modeling_Strategy.md"
                },
                {
                    "Id": 22,
                    "Title": "2.2 Data",
                    "Content": "Content/Section2.2_Data.md"
                },
                {
                    "Id": 23,
                    "Title": "2.3 Model Parameters and Assumptions",
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md"
                }
            ]
        },
        {
            "Id": 3,
            "Title": "3 Results and Discussion",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Id": 31,
                    "Title": "3.1 Final input parameters",
                    "Content": "Content/Input_table.md"
                },
                {
                    "Id": 32,
                    "Title": "3.2 Diagnostics Plots",
                    "Content": "Content/GOF_diagnostics.md"
                },
                {
                    "Id": 33,
                    "Title": "3.3: Concentration-Time Profiles",
                    "Content": "Content/Concentration_time_profiles.md",
                    "Sections": [
                        {
                            "Id": 331,
                            "Title": "3.3.1 Model Building",
                            "Content": "Content/Concentration_time_profiles_building.md"
                        },
                        {
                            "Id": 332,
                            "Title": "3.3.2 Fitted interaction with Midazolam",
                            "Content": "Content/Concentration_time_profiles_mdz_interaction.md"
                        }
                    ]
                }
            ]
        },
        {
            "Id": 4,
            "Title": "4 Conclusion",
            "Content": "Content/Section4_Conclusion.md"
        },
        {
            "Id": 5,
            "Title": "5 References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}